Henovcom Is Invited to Give Presentation at the mRNA Summit

Henovcom is invited to participate in the 4th mRNA-Based Therapeutics Summit in Frankfurt, Germany. The CEO, Jiancun Larry Zhang, will give a presentation titled “Novel & Efficient Cap Analogs & Ionizable Lipids for mRNA Based Vaccines & Therapeutics” and will participate in a case study poster session.

The 4th mRNA-Based Therapeutics Summit Europe is the industry’s premier forum dedicated to showcasing the hottest disease targets, never-before-seen pre-clinical and clinical data, and demonstrating key routes to commercial success for mRNA therapy and vaccine R&D pipelines.

Topic: Novel & Efficient Cap Analogs & Ionizable Lipids for mRNA Based Vaccines & Therapeutics

Date: CONFERENCE DAY one, Wednesday 29th January

Time: 11:45 a.m.

Speaker: Jiancun Larry Zhang

      Chief Executive Officer

Key points:

• Novel trinucloside AG and AU cap analogs amenable to synthesizing mRNAs and saRNAs with an enhanced protein expression profile

• One-pot synthesis of fluorescently labeled mRNA for real-time in vitro and in vivo tracking, and mRNA delivery system screening

• Efficient and fast degrading ionizable lipid for mRNA LNP delivery

• Application of LZCaps in mRNA vaccines and protein replacement therapies

Conference Website：https://mrnabased-therapeutics-europe.com/